Nutex Health, Inc. carries a market capitalization of 1.30B, placing it among publicly traded companies globally. Its enterprise value stands at 1.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.30B |
| Enterprise Value | 1.42B |
Nutex Health, Inc. currently has 6.84M shares outstanding.
| Shares Outstanding | 6.84M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Nutex Health, Inc. trades at a trailing price-to-earnings ratio of 6.51. The price-to-sales ratio is 1.38, and the price-to-book ratio stands at 2.97.
| PE Ratio | 6.51 |
| PS Ratio | 1.38 |
| PB Ratio | 2.97 |
| P/TBV Ratio | 3.25 |
| P/FCF Ratio | 4.26 |
| P/OCF Ratio | 4.19 |
On an enterprise value basis, Nutex Health, Inc. trades at an EV/EBITDA multiple of 3.70 and an EV/FCF ratio of 4.74. The EV/Sales ratio of 1.68 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.91 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.68 |
| EV / EBITDA | 3.70 |
| EV / EBIT | 3.91 |
| EV / FCF | 4.74 |
Nutex Health, Inc. maintains a current ratio of 5.00, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 68.47, indicating elevated leverage, while an interest coverage ratio of 19.48 demonstrates strong ability to service its debt obligations.
| Current Ratio | 5.00 |
| Quick Ratio | 4.79 |
| Debt / Equity | 68.47 |
| Debt / EBITDA | 0.90 |
| Interest Coverage | 19.48 |
Nutex Health, Inc. posts a return on equity of 57.16 and a return on invested capital of 37.20.
| Return on Equity (ROE) | 57.16 |
| Return on Assets (ROA) | 19.93 |
| Return on Invested Capital (ROIC) | 37.20 |
| Return on Capital Employed (ROCE) | 13.41 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 127.33 |
Over the trailing twelve months, Nutex Health, Inc. has paid 70.99M in income taxes, reflecting an effective tax rate of 20.67.
| Income Tax | 70.99M |
| Effective Tax Rate | 20.67 |
Nutex Health, Inc.'s stock has gained approximately 125.86227% over the past 52 weeks. The 50-day moving average sits at 169.84, while the 200-day moving average is 138.74.
| Beta (5Y) | N/A |
| 52-Week Price Change | 125.86227% |
| 50-Day Moving Average | 169.84 |
| 200-Day Moving Average | 138.74 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Nutex Health, Inc. generated 846.72M in revenue and converted that into 179.92M in net income, yielding earnings per share of 38.30. EBITDA reached 385.27M, while operating income came in at 364.27M.
| Revenue | 846.72M |
| Gross Profit | 434.03M |
| Operating Income | 364.27M |
| Pretax Income | 343.48M |
| Net Income | 179.92M |
| EBITDA | 385.27M |
| EBIT | 364.27M |
| Earnings Per Share (EPS) | 38.30 |
Nutex Health, Inc. holds 205.21M in cash and equivalents against 347.34M in total debt, resulting in a net debt position of -165.51M. Total book value stands at 394.32M, with working capital of 468.43M providing operational flexibility.
| Cash & Cash Equivalents | 205.21M |
| Total Debt | 347.34M |
| Net Debt | -165.51M |
| Equity (Book Value) | 394.32M |
| Book Value Per Share | 57.62 |
| Working Capital | 468.43M |
Nutex Health, Inc. produced 279.62M in operating cash flow over the past twelve months. After subtracting -5.45M in capital expenditures, free cash flow totaled 274.17M - equivalent to 40.00 per share.
| Operating Cash Flow | 279.62M |
| Capital Expenditures | -5.45M |
| Free Cash Flow | 274.17M |
| FCF Per Share | 40.00 |
Nutex Health, Inc. operates with a gross margin of 51.26, reflecting its pricing power and cost economics. The operating margin of 43.02 and net profit margin of 21.25 provide insight into operational efficiency.
| Gross Margin | 51.26 |
| Operating Margin | 43.02 |
| Pretax Margin | 40.57 |
| Profit Margin | 21.25 |
| EBITDA Margin | 45.50 |
The company's payout ratio of 23.04 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 12.27 |
| Dividend Yield | N/A |
| Payout Ratio | 23.04 |
| Shareholder Yield | 13.72 |
| FCF Yield | 23.45 |
Nutex Health, Inc.'s most recent stock split took place on July 3, 2024 with a 10:1 split ratio.
| Last Split Date | 7/3/2024 |
| Split Ratio | 10:1 |
Nutex Health, Inc. posts an Altman Z-Score of 4.08, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.08 |